india glp 1 Did you know? is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up in diabetes & obesity care #MarketTalks #EdelweissMutualFund GLP 1: Just a wonder
Description
3.0%6.6% and 0.4% of patients in the respective groups discontinued treatment because of these adverse events (54)
These can include nausea, constipation, diarrhea, reflux, bloating, decreased appetite, abdominal discomfort, or vomiting
Through this link, GLP-1 drugs can play a role in regulating dopamine pathways that are highly relevant in addictive behaviours
The covered medications include drugmaker Eli Lillys Foundayo tablets and Zepbound KwikPens and Novo Nordisks Wegovy injections and tablets, all of which have been FDA-approved for weight loss, according to the report
As more people take Zepbound for weight loss, more people will experience the dangerous side effects of the drug and file lawsuits
Matsueda K, Hongo M, Tack J, Saito Y, Kato H
